全文获取类型
收费全文 | 23804篇 |
免费 | 1245篇 |
国内免费 | 87篇 |
专业分类
耳鼻咽喉 | 137篇 |
儿科学 | 397篇 |
妇产科学 | 385篇 |
基础医学 | 3070篇 |
口腔科学 | 752篇 |
临床医学 | 1738篇 |
内科学 | 5712篇 |
皮肤病学 | 431篇 |
神经病学 | 2176篇 |
特种医学 | 1040篇 |
外科学 | 3609篇 |
综合类 | 89篇 |
预防医学 | 690篇 |
眼科学 | 485篇 |
药学 | 1867篇 |
中国医学 | 56篇 |
肿瘤学 | 2502篇 |
出版年
2023年 | 117篇 |
2022年 | 234篇 |
2021年 | 407篇 |
2020年 | 243篇 |
2019年 | 341篇 |
2018年 | 378篇 |
2017年 | 300篇 |
2016年 | 380篇 |
2015年 | 411篇 |
2014年 | 546篇 |
2013年 | 669篇 |
2012年 | 1014篇 |
2011年 | 1179篇 |
2010年 | 593篇 |
2009年 | 557篇 |
2008年 | 1007篇 |
2007年 | 1024篇 |
2006年 | 998篇 |
2005年 | 1004篇 |
2004年 | 976篇 |
2003年 | 952篇 |
2002年 | 1026篇 |
2001年 | 924篇 |
2000年 | 956篇 |
1999年 | 928篇 |
1998年 | 305篇 |
1997年 | 238篇 |
1996年 | 227篇 |
1995年 | 184篇 |
1994年 | 168篇 |
1993年 | 164篇 |
1992年 | 665篇 |
1991年 | 580篇 |
1990年 | 608篇 |
1989年 | 585篇 |
1988年 | 504篇 |
1987年 | 471篇 |
1986年 | 458篇 |
1985年 | 405篇 |
1984年 | 279篇 |
1983年 | 245篇 |
1980年 | 97篇 |
1979年 | 244篇 |
1978年 | 143篇 |
1977年 | 128篇 |
1975年 | 101篇 |
1974年 | 95篇 |
1972年 | 107篇 |
1971年 | 104篇 |
1969年 | 102篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Kota Sahara Rin Yamada Takashi Fujiwara Koichi Koizumi Shin‐ichiro Horiguchi Tsunekazu Hishima Tatsuro Yamaguchi 《Digestive endoscopy》2015,27(7):768-771
Idiopathic myointimal hyperplasia of mesenteric veins (IMHMV) is a rare and poorly understood ischemic colitis that occurs in the rectosigmoid colon of predominantly young, previously healthy, male patients. A 76‐year‐old Japanese man presented to our hospital with a 1‐year history of worsening diarrhea, lower abdominal pain, and weight loss (−6 kg). Laboratory evaluation revealed white blood cell count of 13 200/μL, C‐reactive protein level of 2.0 mg/dL (normal range, 0.0–0.3), and negative results for stool culture (including Clostridium difficile). Colonoscopy showed circumferential and edematous narrowing of the sigmoid colon with deep longitude ulceration. Biopsy was done and examination of the specimen demonstrated no specific ischemia. The patient was treated with bowel rest, antibiotics, and i.v. fluids; however, his symptoms worsened. Finally, sigmoidectomy was carried out. Histological examination demonstrated significant myointimal hyperplasia of mesenteric veins leading to thickening and stenosis of the venous lumen. Therefore, the final diagnosis was IMHMV. Three months following sigmoidectomy, he was asymptomatic. 相似文献
3.
4.
5.
6.
7.
Jun Agata Nobuyuki Ura Hideaki Yoshida Yasuyuki Shinshi Haruki Sasaki Masaya Hyakkoku Shinya Taniguchi Kazuaki Shimamoto 《Hypertension research》2006,29(11):865-874
Angiotensin II receptor blockers (ARBs) are widely used for the treatment of hypertension. It is believed that treatment with an ARB increases the level of plasma angiotensin II (Ang II) because of a lack of negative feedback on renin activity. However, Ichikawa (Hypertens Res 2001; 24: 641-646) reported that long-term treatment of hypertensive patients with olmesartan resulted in a reduction in plasma Ang II level, though the mechanism was not determined. It has been reported that angiotensin 1-7 (Ang-(1-7)) potentiates the effect of bradykinin and acts as an angiotensin-converting enzyme (ACE) inhibitor. It is known that ACE2, which was discovered as a novel ACE-related carboxypeptidase in 2000, hydrolyzes Ang I to Ang-(1-9) and also Ang II to Ang-(1-7). It has recently been reported that olmesartan increases plasma Ang-(1-7) through an increase in ACE2 expression in rats with myocardial infarction. We hypothesized that over-expression of ACE2 may be related to a reduction in Ang II level and the cardioprotective effect of olmesartan. Administration of 0.5 mg/kg/day of olmesartan for 4 weeks to 12-week-old stroke-prone spontaneously hypertensive rats (SHRSP) significantly reduced blood pressure and left ventricular weight compared to those in SHRSP given a vehicle. Co-administration of olmesartan and (D-Ala7)-Ang-(1-7), a selective Ang-(1-7) antagonist, partially inhibited the effect of olmesartan on blood pressure and left ventricular weight. Interestingly, co-administration of (D-Ala7)-Ang-(1-7) with olmesartan significantly increased the plasma Ang II level (453.2+/-113.8 pg/ml) compared to olmesartan alone (144.9+/-27.0 pg/ml, p<0.05). Moreover, olmesartan significantly increased the cardiac ACE2 expression level compared to that in Wistar Kyoto rats and SHRSP treated with a vehicle. Olmesartan significantly improved cardiovascular remodeling and cardiac nitrite/ nitrate content, but co-administration of olmesartan and (D-Ala7)-Ang-(1-7) partially reversed this anti-remodeling effect and the increase in nitrite/nitrate. These findings suggest that olmesartan may exhibit an ACE inhibitory action in addition to an Ang II receptor blocking action, prevent an increase in Ang II level, and protect cardiovascular remodeling through an increase in cardiac nitric oxide production and endogenous Ang-(1-7) via over-expression of ACE2. 相似文献
8.
9.
Experiments were performed on spinalized rats, transected at the Cl level. The intravenous administration of TRH and its analog YM-14673 (N alpha-[(S)-4-oxo-2-azetidinyl) carbonyl]-L-histidyl-L-prolinamide dehydrate) produced marked increases in the amplitude of mono- and polysynaptic reflex potentials and those of the withdrawal flexor reflexes. The effects of YM-14673 were stronger and longer-lasting than those of TRH. The stimulant action of TRH and YM-14673 on the flexor reflexes was not antagonized by prazosin, chlorpromazine, haloperidol or cyproheptadine, suggesting no involvement of the release of catecholamines or serotonin in the stimulant effects of TRH and its analog. Therefore, YM-14673 may be beneficial for the treatment of several spinal motor neuron diseases. 相似文献
10.
S Yamada 《Journal of UOEH》1988,10(2):211-218
Physical activity and nutrition are the most important factors in preserving and/or improving health conditions. The relationship between exercise and nutrition is focused on two different directions: one is the direction toward health promoting, the other is for performance of a long heavy muscular work. For preserving and/or promoting health conditions, energy balance between intake and expenditure must be taken into account. The amount of glycogen stored in muscles is the essential factor to promote a long distance performance of working muscles. Topics that influence the energy balance and glycogen loading used by endurance athletes to improve performance are reviewed. 相似文献